LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 28

Search options

  1. Article ; Online: A brief history of the development of a gene doping test.

    Baoutina, Anna

    Bioanalysis

    2020  Volume 12, Issue 11, Page(s) 723–727

    MeSH term(s) Athletes ; Doping in Sports ; Genetic Testing ; Humans ; Substance Abuse Detection
    Language English
    Publishing date 2020-04-23
    Publishing country England
    Document type Editorial
    ISSN 1757-6199
    ISSN (online) 1757-6199
    DOI 10.4155/bio-2020-0056
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Novel design of nucleic acid standards for hydrolysis probe-based PCR with melting analysis.

    Baoutina, Anna / Bhat, Somanath

    Gene therapy

    2021  Volume 29, Issue 7-8, Page(s) 425–430

    Abstract: Probe-based polymerase chain reaction (PCR), a popular method in genetic testing, could be prone to false positive or positively biased results if standards used for positive controls or as calibrants accidentally contaminate samples during analysis. To ... ...

    Abstract Probe-based polymerase chain reaction (PCR), a popular method in genetic testing, could be prone to false positive or positively biased results if standards used for positive controls or as calibrants accidentally contaminate samples during analysis. To prevent this, a unique design strategy for nucleic acid standards has been developed. Several in-house designed synthetic standards and corresponding test targets were analysed in specific probe-based PCR assays in the presence of SYTO 82™, an intercalating dye compatible with a probe-labelling FAM (6-Carboxyfluorescein) fluorophore. PCR was followed by melting and fragment size analyses. We showed that a standard can be designed to allow discrimination from the test target in post-PCR melting analysis based on differences in melting temperature (Tm). A good predictor of Tm differences for the paired amplicons was the software package uMelt, but not the length of the amplicons nor guanine-cytosine (GC) content. Tm-based determination can be complimented by electrophoresis to measure differences in amplicons' length. Designing genetic standards using the described method for tests that utilise probe-based PCR will prevent false positive and inaccurate results, while also simplifying the test and reducing its cost.
    MeSH term(s) Fluorescent Dyes ; Hydrolysis ; Nucleic Acids/genetics ; Polymerase Chain Reaction/methods ; Temperature
    Chemical Substances Fluorescent Dyes ; Nucleic Acids
    Language English
    Publishing date 2021-08-19
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1191036-7
    ISSN 1476-5462 ; 0969-7128
    ISSN (online) 1476-5462
    ISSN 0969-7128
    DOI 10.1038/s41434-021-00288-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: PCR-Based Equine Gene Doping Test for the Australian Horseracing Industry.

    Wilkin, Tessa / Hamilton, Natasha A / Cawley, Adam T / Bhat, Somanath / Baoutina, Anna

    International journal of molecular sciences

    2024  Volume 25, Issue 5

    Abstract: The term 'gene doping' is used to describe the use of any unauthorized gene therapy techniques. We developed a test for five likely candidate genes for equine gene doping: ...

    Abstract The term 'gene doping' is used to describe the use of any unauthorized gene therapy techniques. We developed a test for five likely candidate genes for equine gene doping:
    MeSH term(s) Animals ; Horses/genetics ; Erythropoietin/genetics ; Australia ; Plasmids ; DNA/genetics ; Real-Time Polymerase Chain Reaction
    Chemical Substances Erythropoietin (11096-26-7) ; DNA (9007-49-2)
    Language English
    Publishing date 2024-02-22
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms25052570
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Towards a robust test to detect gene doping for anabolic enhancement in human athletes.

    Baoutina, Anna / Bhat, Somanath / Li, Desmond K / Emslie, Kerry R

    Drug testing and analysis

    2022  Volume 15, Issue 3, Page(s) 314–323

    Abstract: Success in gene therapy in treating human disease makes this technology attractive to enhance athletic performance, creating the need for gene doping detection. In 2021, World Anti-Doping Agency (WADA) approved the first gene doping test. Here, we ... ...

    Abstract Success in gene therapy in treating human disease makes this technology attractive to enhance athletic performance, creating the need for gene doping detection. In 2021, World Anti-Doping Agency (WADA) approved the first gene doping test. Here, we describe a new method to detect doping with four additional genes, follistatin, growth hormone 1, growth hormone-releasing hormone and insulin-like growth factor 1, that may improve performance by increasing muscle size and strength. The method utilises four hydrolysis probe-based polymerase chain reaction (PCR) assays that target the transgenes based on the coding sequence of the four endogenous genes. The assays are specific, reproducible and capable to detect five copies of transgene in the presence of very similar endogenous gene in 25,000 times excess. To underpin reliable and comparable routine method performance by doping testing laboratories, a synthetic reference material for the method was designed and generated following the ISO Guide 35. The complete method was validated in blood samples using plasma as extraction matrix and QIAamp DNA blood midi DNA extraction kit. All blood samples from different donors (n = 8) simulated to be negative or positive (1500 transgene copies spiked per millilitre of blood) for the transgenes were reported correctly. The new method that targets four additional genes will extend the capabilities of laboratories involved in doping control to protect athletes' health, fairness and equality.
    MeSH term(s) Humans ; Athletes ; Transgenes ; Polymerase Chain Reaction/methods ; Genetic Therapy ; DNA ; Doping in Sports
    Chemical Substances DNA (9007-49-2)
    Language English
    Publishing date 2022-12-18
    Publishing country England
    Document type Journal Article
    ZDB-ID 2462336-2
    ISSN 1942-7611 ; 1942-7603
    ISSN (online) 1942-7611
    ISSN 1942-7603
    DOI 10.1002/dta.3411
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Storage Stability of Solutions of DNA Standards.

    Baoutina, Anna / Bhat, Somanath / Partis, Lina / Emslie, Kerry R

    Analytical chemistry

    2019  Volume 91, Issue 19, Page(s) 12268–12274

    Abstract: High accuracy, reliability, and reproducibility of genetic analyses in various applications require optimized and validated protocols and standards. Optimal procedures for storing the genetic material extracted from biological samples are equally ... ...

    Abstract High accuracy, reliability, and reproducibility of genetic analyses in various applications require optimized and validated protocols and standards. Optimal procedures for storing the genetic material extracted from biological samples are equally important. In this study, we investigated the stability of dilute (4000 cp/μL, nominal concentration, equivalent to 0.02 ng/mL) DNA solutions stored at 4, -20, and -80 °C in the presence or absence of nucleic acid carriers. As representative examples, we used different formulations of a linearized plasmid DNA solution considered for characterization as reference materials (RMs) for specific applications. Employing droplet digital PCR, a highly accurate and precise method for quantification of nucleic acid not requiring a calibrant, we demonstrated that inclusion of a carrier nucleic acid in the formulation (at 50 ng/μL) improved the plasmid stability at -20 and -80 °C. For the case of a DNA standard used in real-time PCR assays for human erythropoietin gene, cDNA or transcript, we found that inclusion of yeast RNA in the formulation was preferred over salmon testes DNA as it had no effect on PCR amplification and provided the lowest relative expanded uncertainty for the characterized RM. RNA background may also be preferred as it is applicable to a broader range of DNA RMs. Our findings are important in production of reliable, stable DNA standards, including DNA RMs. These results can be used when selecting protocols for stable storage of DNA either extracted from biological samples or synthesized in a laboratory.
    MeSH term(s) Animals ; DNA/chemistry ; DNA/standards ; Erythropoietin/genetics ; Freezing ; Humans ; Plasmids ; Quality Control ; Real-Time Polymerase Chain Reaction/standards ; Reference Standards ; Reproducibility of Results ; Salmon/genetics ; Temperature
    Chemical Substances EPO protein, human ; Erythropoietin (11096-26-7) ; DNA (9007-49-2)
    Language English
    Publishing date 2019-09-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1508-8
    ISSN 1520-6882 ; 0003-2700
    ISSN (online) 1520-6882
    ISSN 0003-2700
    DOI 10.1021/acs.analchem.9b02334
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Equine performance genes and the future of doping in horseracing.

    Wilkin, Tessa / Baoutina, Anna / Hamilton, Natasha

    Drug testing and analysis

    2017  Volume 9, Issue 9, Page(s) 1456–1471

    Abstract: A horse's success on the racetrack is determined by genetics, training and nutrition, and their translation into physical traits such as speed, endurance and muscle strength. Advances in genetic technologies are slowly explaining the roles of specific ... ...

    Abstract A horse's success on the racetrack is determined by genetics, training and nutrition, and their translation into physical traits such as speed, endurance and muscle strength. Advances in genetic technologies are slowly explaining the roles of specific genes in equine performance, and offering new insights into the development of novel therapies for diseases and musculoskeletal injuries that cause early retirement of many racehorses. Gene therapy approaches may also soon provide new means to artificially enhance the physical performance of racehorses. Gene doping, the misuse of gene therapies for performance enhancement, is predicted to be the next phase of doping faced by horseracing. The risk of gene doping to human sports has been recognised for almost 15 years, and the introduction of the first gene doping detection tests for doping control in human athletes is imminent. Gene doping is also a threat to horseracing, but there are currently no methods to detect it. Efficient and accurate detection methods need to be developed to deter those looking to use gene doping in horses and to maintain the integrity of the sport. Methods developed for human athletes could offer an avenue for detection in racehorses. Development of an equine equivalent test will first require identification of equine genes that will likely be targeted by gene doping attempts. This review focuses on genes that have been linked to athletic performance in horses and, therefore, could be targeted for genetic manipulation. The risks associated with gene doping and approaches to detect gene doping are also discussed. Copyright © 2017 John Wiley & Sons, Ltd.
    MeSH term(s) Animals ; Athletic Performance ; Doping in Sports/methods ; Horses ; Humans
    Language English
    Publishing date 2017-09
    Publishing country England
    Document type Journal Article
    ZDB-ID 2462336-2
    ISSN 1942-7611 ; 1942-7603
    ISSN (online) 1942-7611
    ISSN 1942-7603
    DOI 10.1002/dta.2198
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Storage Stability of Solutions of DNA Standards

    Baoutina, Anna / Bhat, Somanath / Partis, Lina / Emslie, Kerry R

    Analytical chemistry. 2019 Aug. 29, v. 91, no. 19

    2019  

    Abstract: High accuracy, reliability, and reproducibility of genetic analyses in various applications require optimized and validated protocols and standards. Optimal procedures for storing the genetic material extracted from biological samples are equally ... ...

    Abstract High accuracy, reliability, and reproducibility of genetic analyses in various applications require optimized and validated protocols and standards. Optimal procedures for storing the genetic material extracted from biological samples are equally important. In this study, we investigated the stability of dilute (4000 cp/μL, nominal concentration, equivalent to 0.02 ng/mL) DNA solutions stored at 4, −20, and −80 °C in the presence or absence of nucleic acid carriers. As representative examples, we used different formulations of a linearized plasmid DNA solution considered for characterization as reference materials (RMs) for specific applications. Employing droplet digital PCR, a highly accurate and precise method for quantification of nucleic acid not requiring a calibrant, we demonstrated that inclusion of a carrier nucleic acid in the formulation (at 50 ng/μL) improved the plasmid stability at −20 and −80 °C. For the case of a DNA standard used in real-time PCR assays for human erythropoietin gene, cDNA or transcript, we found that inclusion of yeast RNA in the formulation was preferred over salmon testes DNA as it had no effect on PCR amplification and provided the lowest relative expanded uncertainty for the characterized RM. RNA background may also be preferred as it is applicable to a broader range of DNA RMs. Our findings are important in production of reliable, stable DNA standards, including DNA RMs. These results can be used when selecting protocols for stable storage of DNA either extracted from biological samples or synthesized in a laboratory.
    Keywords complementary DNA ; droplets ; erythropoietin ; genes ; genetic analysis ; humans ; messenger RNA ; plasmids ; quantitative polymerase chain reaction ; salmon ; storage quality ; testes ; uncertainty ; yeasts
    Language English
    Dates of publication 2019-0829
    Size p. 12268-12274.
    Publishing place American Chemical Society
    Document type Article
    ZDB-ID 1508-8
    ISSN 1520-6882 ; 0003-2700
    ISSN (online) 1520-6882
    ISSN 0003-2700
    DOI 10.1021/acs.analchem.9b02334
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article ; Online: Synthetic certified DNA reference material for analysis of human erythropoietin transgene and transcript in gene doping and gene therapy.

    Baoutina, A / Bhat, S / Zheng, M / Partis, L / Dobeson, M / Alexander, I E / Emslie, K R

    Gene therapy

    2016  Volume 23, Issue 10, Page(s) 708–717

    Abstract: There is a recognised need for standardisation of protocols for vector genome analysis used in vector manufacturing, to establish dosage, in biodistribution studies and to detect gene doping in sport. Analysis of vector genomes and transgene expression ... ...

    Abstract There is a recognised need for standardisation of protocols for vector genome analysis used in vector manufacturing, to establish dosage, in biodistribution studies and to detect gene doping in sport. Analysis of vector genomes and transgene expression is typically performed by qPCR using plasmid-based calibrants incorporating transgenic sequences. These often undergo limited characterisation and differ between manufacturers, potentially leading to inaccurate quantification, inconsistent inter-laboratory results and affecting clinical outcomes. Contamination of negative samples with such calibrants could cause false positive results. We developed a design strategy for synthetic reference materials (RMs) with modified transgenic sequences to prevent false positives due to cross-contamination. When such RM is amplified in transgene-specific assays, the amplicons are distinguishable from transgene's amplicons based on size and sequence. Using human erythropoietin as a model, we produced certified RM according to this strategy and following ISO Guide 35. Using non-viral and viral vectors, we validated the effectiveness of this RM in vector genome analysis in blood in vitro. The developed design strategy could be applied to production of RMs for other transgenes, genes or transcripts. Together with validated PCR assays, such RMs form a measurement tool that facilitates standardised, accurate and reliable genetic analysis in various applications.
    MeSH term(s) DNA, Recombinant/genetics ; DNA, Recombinant/metabolism ; Erythropoietin/genetics ; Erythropoietin/metabolism ; Genetic Therapy/standards ; Humans ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; RNA, Messenger/standards ; Reference Standards ; Transgenes
    Chemical Substances DNA, Recombinant ; RNA, Messenger ; Erythropoietin (11096-26-7)
    Language English
    Publishing date 2016-10
    Publishing country England
    Document type Journal Article
    ZDB-ID 1191036-7
    ISSN 1476-5462 ; 0969-7128
    ISSN (online) 1476-5462
    ISSN 0969-7128
    DOI 10.1038/gt.2016.47
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Gene doping detection: evaluation of approach for direct detection of gene transfer using erythropoietin as a model system.

    Baoutina, A / Coldham, T / Bains, G S / Emslie, K R

    Gene therapy

    2010  Volume 17, Issue 8, Page(s) 1022–1032

    Abstract: As clinical gene therapy has progressed toward realizing its potential, concern over misuse of the technology to enhance performance in athletes is growing. Although 'gene doping' is banned by the World Anti-Doping Agency, its detection remains a major ... ...

    Abstract As clinical gene therapy has progressed toward realizing its potential, concern over misuse of the technology to enhance performance in athletes is growing. Although 'gene doping' is banned by the World Anti-Doping Agency, its detection remains a major challenge. In this study, we developed a methodology for direct detection of the transferred genetic material and evaluated its feasibility for gene doping detection in blood samples from athletes. Using erythropoietin (EPO) as a model gene and a simple in vitro system, we developed real-time PCR assays that target sequences within the transgene complementary DNA corresponding to exon/exon junctions. As these junctions are absent in the endogenous gene due to their interruption by introns, the approach allows detection of trace amounts of a transgene in a large background of the endogenous gene. Two developed assays and one commercial gene expression assay for EPO were validated. On the basis of ability of these assays to selectively amplify transgenic DNA and analysis of literature on testing of gene transfer in preclinical and clinical gene therapy, it is concluded that the developed approach would potentially be suitable to detect gene doping through gene transfer by analysis of small volumes of blood using regular out-of-competition testing.
    MeSH term(s) Athletes ; Athletic Performance ; Doping in Sports/prevention & control ; Erythropoietin/genetics ; Gene Transfer Techniques ; Genetic Therapy ; Humans ; Polymerase Chain Reaction/methods ; Reproducibility of Results ; Transgenes
    Chemical Substances Erythropoietin (11096-26-7)
    Language English
    Publishing date 2010-08
    Publishing country England
    Document type Evaluation Studies ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1191036-7
    ISSN 1476-5462 ; 0969-7128
    ISSN (online) 1476-5462
    ISSN 0969-7128
    DOI 10.1038/gt.2010.49
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: alpha-Tocopherol in atherogenesis: do we know its real role?

    Neuzil, J / Baoutina, A

    Cardiovascular drugs and therapy

    1998  Volume 12, Issue 5, Page(s) 421–423

    MeSH term(s) Antioxidants/therapeutic use ; Arteriosclerosis/drug therapy ; Dietary Supplements ; Humans ; Vitamin E/therapeutic use
    Chemical Substances Antioxidants ; Vitamin E (1406-18-4)
    Language English
    Publishing date 1998-10
    Publishing country United States
    Document type Editorial ; Review
    ZDB-ID 639068-7
    ISSN 1573-7241 ; 0920-3206
    ISSN (online) 1573-7241
    ISSN 0920-3206
    DOI 10.1023/a:1007782012646
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top